Coronary Revascularisation in Diabetic Patients with Multivessel Disease: Coronary Artery Bypass Grafting versus Percutaneous Coronary InterventionShabnam Rashid*
Leeds General Infirmary, Great George Street, Leeds, West Yorkshire, LS1 3EX, UK
- *Corresponding Author:
- Dr Shabnam Rashid, BSc, MBChB
Leeds General Infirmary, Great George Street
Leeds, West Yorkshire, LS1 3EX, UK
Tel: 0113 2432799
Fax: 0113 3925751
E-mail: [email protected]
Received date: September 02, 2016; Accepted date: November 11, 2016; Published date: November 17, 2016
Citation: Rashid S (2016) Coronary Revascularisation in Diabetic Patients with Multivessel Disease; Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention. J Thrombo Cir 2:116.
Copyright: © 2016 Rashid S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Patients with diabetes mellitus and coronary disease have a higher mortality compared to individuals with coronary disease in the absence of diabetes mellitus. A significant proportion of patients with diabetes mellitus have combined risk factors for coronary artery disease including hypertension and hyperlipidaemia. The presence of underlying chronic inflammation and endothelial dysfunction further adds to the increased incidence of coronary disease in these patients. Revascularisation is indicated in patients with severe coronary artery disease. Coronary artery bypass grafting is recommended over percutaneous coronary intervention in patients with diabetes mellitus and multivessel disease as several trials have demonstrated the superiority of coronary artery bypass grafting in these patients. Major adverse cardiovascular and cerebrovascular events are higher in diabetic patients with multivessel disease who undergo percutaneous coronary intervention when compared to coronary artery bypass grafting.